News
Guiding criteria for single reimbursement for Multaq®
(07.09.2010)
DKMAnet is up and running again
(06.09.2010)
Minutes of Reimbursement Committee meeting no. 338
(06.09.2010)
Minutes of Reimbursement Committee meeting no. 337 (Reassessment of reimbursement)
(06.09.2010)
Case handling times for clinical trials
(03.09.2010)
Amendment of Danish executive order on euphoriant substances
(03.09.2010)
Danish Pharmacovigilance Update
(02.09.2010)
EudraCT portal available 2 - 7 September 2010
(02.09.2010)
Much debated dental crowns pose no health risk
(02.09.2010)
About gold dental crowns from Oversea Labs: Experts assess there to be no health risk associated with the dental crowns
(31.08.2010)
Sales of head lice medicines
(31.08.2010)
Decisions on general reimbursement for medicinal products
(31.08.2010)
Indication, 30 July 2010
(27.08.2010)
EudraCT portal unavailable 2 - 7 September 2010
(27.08.2010)
The Danish Medicines Agency’s expectations for audits of API manufacturers
(27.08.2010)
Evaluation of possible link between Pandemrix® and narcolepsy
(26.08.2010)
Medicinal Product Statistics in Denmark 2005-2009
(23.08.2010)
Guiding criteria for single reimbursement for Toctino®
(20.08.2010)
Report on the blood product area in 2009
(20.08.2010)
Minutes of Reimbursement Committee meeting no. 335
(18.08.2010)
Minutes of meeting no. 27 of the Council for Adverse Drug Reactions
(18.08.2010)
Pamphlet on reporting side effects from medicine
(18.08.2010)
Indication, 2 July 2010
(17.08.2010)
OTC medicines and release for sale outside pharmacies
(12.08.2010)
137th session of the European Pharmacopoeia Commission
(11.08.2010)
Medicines for treatment of head lice
(09.08.2010)
Danish authorities assess risk of calcium supplements
(09.08.2010)
Dates of meetings for the Danish Pharmacopoeia Commission
(05.08.2010)
General development of medicines used in Denmark
(04.08.2010)
Conclusions and recommendations from the Pharmaceutical Forum
(27.07.2010)
EMA reassesses cardiovascular safety of rosiglitazone-containing medicines (Avandia, Avandamet and Avaglim)
(26.07.2010)
Updated monographs for Heparin calcium (0332) and Heparin sodium (0333) for implementation in the European Pharmacopoeia (Ph. Eur.) as of 1 August 2010
(22.07.2010)
Assessment times for authorisation of medicinal products
(19.07.2010)
Change of the reimbursement for certain cardiovascular products as of 15 November 2010
(14.07.2010)
Changes in reimbursements for drugs for acid-related disorders as of 15 November 2010
(14.07.2010)
Consultation on the Heads of Medicines Agencies’ Strategy Paper for 2011-2015
(13.07.2010)
Assessment times for authorisation of medicinal products
(12.07.2010)
Conversion from AIP (pharmacy purchase price) to ESP (consumer price)
(12.07.2010)
Follow-up on adverse reaction reports
(09.07.2010)
Licensing of medicines – prioritisation and forecast processing times for the second half of 2010
(09.07.2010)
Sun, heat and medicine
(09.07.2010)
Procedure for testing exchange of E2B files with the Danish Medicines Agency
(07.07.2010)
Side effects from Eltroxin® - status July 2010
(05.07.2010)
Notification to medicines manufacturers about reduced testing of starting materials
(05.07.2010)
Increasing use of expensive strong pain-relieving medicines in Denmark
(05.07.2010)
Minutes of meeting no. 5 of the Network for the Prevention of Medication Errors held on 14 April 2010
(02.07.2010)
Minutes of Licensing Committee meeting no. 1/2010
(02.07.2010)
Danish Pharmacovigilance Update no. 8, 17 June 2010
(02.07.2010)
General development of medicines used in Denmark
(29.06.2010)
Product defects and withdrawal of medicinal products in 2009
(29.06.2010)
Total sales of medicines in Denmark
(29.06.2010)
Pharmaceutical price indices
(29.06.2010)
Annual report 2009 of the Danish Medicines Agency's laboratory control activities
(23.06.2010)
Danish Chair of European group of experts
(16.06.2010)
Implementation of Braille (raised dots for the blind and partially sighted) on medicine packages
(15.06.2010)
Monitor the trends in consumption of cardiovascular medicines
(14.06.2010)
New practice for authorisation of qualified persons on section 39 authorisations
(11.06.2010)
Amendment of executive order on euphoriant substances
(10.06.2010)
Indication, 26 May 2010
(09.06.2010)
The Danish Medicines Agency’s practice – naming of medicinal products
(08.06.2010)
DKMAnet is up and running again
(04.06.2010)
DKMAnet.dk is temporarily unavailable
(04.06.2010)
Consultation responses on the Reimbursement Committee’s recommendation concerning the reimbursement status of medicinal products in ATC groups C09C, C09D and C09X (angiotensin II antagonists and renin inhibitors)
(03.06.2010)
Annual report of the Reimbursement Committee 2009
(03.06.2010)
Campaign at Danish pharmacies: ”Help us make medicine better for all”
(01.06.2010)
Danish Pharmacovigilance Update no. 7, 20 May 2010
(28.05.2010)
Number of cases on the authorisation of medicinal products in 2010
(27.05.2010)
Statistics for 2009 on the sale of medicinal products in Denmark now available
(26.05.2010)
Indication, 21 April 2010
(21.05.2010)
Report on compliance with rules on good manufacturing practice by manufacturers of active pharmaceutical ingredients
(20.05.2010)
Minutes of Reimbursement Committee meeting no. 334 (Reassessment of reimbursement)
(17.05.2010)
Minutes of Reimbursement Committee meeting no. 333
(17.05.2010)
Side effects from Pandemrix® from 23 January to 18 April 2010
(10.05.2010)
Voluntary Harmonisation Procedure (VHP) for the assessment of multinational clinical trial applications
(05.05.2010)
Danish Pharmacovigilance Update no. 6, 15 April 2010
(04.05.2010)
Danish Medicines Agency’s annual pharmacovigilance report 2009
(04.05.2010)
Upgrade of the Danish Medicines Agency’s system for electronic transmission of adverse reaction reports via Eudravigilance gateway
(04.05.2010)
Number of applications for individual reimbursement of medicinal products in 2009
(27.04.2010)
Minutes of Reimbursement Committee meeting no. 332 (Reassessment of reimbursement)
(23.04.2010)
Minutes of Reimbursement Committee meeting no. 331
(23.04.2010)
Decision on future reimbursement status of losartan-containing medicines (C09CA01 and C09DA01) - angiotensin II antagonists
(21.04.2010)
The Danish Medicines Agency resumes the allocation of time slots for the second half of 2011
(21.04.2010)
The Danish population's use of medicines against major preventable diseases and disorders, by municipality
(21.04.2010)
Conversion from AIP (pharmacy purchase price) to ESP (consumer price)
(19.04.2010)
More than a 10-fold increase in the number of people treated with ADHD drugs in the last 10 years in Denmark
(16.04.2010)
Danish Pharmacovigilance Update no. 5, 18 March 2010
(15.04.2010)
The Danish Medicines Act
(12.04.2010)
136th session of the European Pharmacopoeia Commission
(09.04.2010)
Consultation responses on the Reimbursement Committee’s recommendation concerning the reimbursement status of medicinal products in ATC group A02 (drugs for acid related disorders)
(09.04.2010)
The Danish Medicines Agency warns against the use of silicone breast implants manufactured by Poly Implant Prothèse, France
(09.04.2010)
Ad hoc repackaging of medicinal products with marketing authorisation
(07.04.2010)
Continued drop in use of benzodiazepines
(31.03.2010)
Consultation on the Reimbursement Committee's recommendation concerning the reimbursement status of medicinal products in ATC groups C09C, C09D and C09X (angiotensin II antagonists and renin inhibitors)
(31.03.2010)
Danish Pharmacovigilance Update no. 4, 18 February 2010
(29.03.2010)
EMA recommends recall of clopidogrel products from Acino Pharma GmbH
(26.03.2010)
The Danish Medicines Agency begins ad hoc reassessment of reimbursement status of medicines in ATC groups C09C, C09D and C09X
(24.03.2010)
EMA updates warning on clopidogrel-containing medicines
(22.03.2010)
Agreement on improved workflow for follow-up reporting
(22.03.2010)
Indication, 4 March 2010
(22.03.2010)
Strengthened warning against Alscreme 'Creme nr. 2' from www.eminescu.dk
(10.03.2010)
Danish Medicines Agency co-organises biosimulation workshop on 11 March 2010
(10.03.2010)
Chief Medical Officer of the Danish Medicines Agency appointed new member of the EU Pharmacovigilance Working Party
(08.03.2010)
Amendment of executive order on euphoriant substances
(05.03.2010)
Medicines retained by Danish customs
(03.03.2010)
Updating of summary of product characteristics prompted by changed ATC codes for 2010
(03.03.2010)
Number of cases on the authorisation of medicinal products in 2009
(02.03.2010)
Danish Pharmacovigilance Update no. 3, 21 January 2010
(02.03.2010)
Monitor the trends in consumption of cardiovascular medicines
(25.02.2010)
Adverse reactions from Gardasil® in the period 1 September – 31 December 2009
(25.02.2010)
Focus on safe handling and use of pain-relief patches
(24.02.2010)
Spot checking of distribution of medical samples for the year 2007
(19.02.2010)
Warning against ‘Alscreme Creme nr. 2’ from www.eminescu.dk
(16.02.2010)
Minutes of Reimbursement Committee meeting no. 329
(12.02.2010)
Minutes of Reimbursement Committee meeting no. 328
(12.02.2010)
Email problems now solved
(10.02.2010)
The Danish Medicines Agency's questions and answers on variations after 1 January 2010
(09.02.2010)
Problems receiving emails at the Danish Medicines Agency
(08.02.2010)
Import of medicinal products from third countries
(08.02.2010)
Indication, 23 December 2009
(04.02.2010)
Compliance check of package leaflets and product labelling (winter 2009/2010)
(03.02.2010)
Licensing of medicines – prioritisation and forecast processing times for the first half of 2010
(03.02.2010)
Side effects from Pandemrix® from 9 to 22 January 2010
(29.01.2010)
Warning against pills from IDS Sports
(29.01.2010)
Danish Pharmacovigilance Update no. 2, 17 December 2009
(27.01.2010)
Updated warning against counterfeit Alli® from the USA
(27.01.2010)
Change of the content of the fields ’Number of DDD per package’ and ’Price per DDD’
(26.01.2010)
New practice for authorisation of contract acceptors on section 39 authorisations
(26.01.2010)
Vacancy for an Executive Director of the European Medicines Agency
(26.01.2010)
Price development of liberalised medicines sold in Denmark 2004 - 2008
(26.01.2010)
Monitor the trends in consumption of cardiovascular medicines
(25.01.2010)
European Medicines Agency recommends suspension of marketing authorisations for sibutramine due to increased risk of cardiovascular events
(22.01.2010)
Guideline on variations to marketing authorisations for medicinal products
(22.01.2010)
Dates of meetings for the Reimbursement Committee
(21.01.2010)
Information about variation applications from 1 January 2010
(21.01.2010)
Considerable increase in consumption of antidiabetic drugs from 1999 to 2008 in Denmark
(21.01.2010)
Indication, 30 October 2009
(20.01.2010)
Warning against counterfeit Alli® from the USA
(19.01.2010)
Side effects from Pandemrix® from 19 December 2009 to 8 January 2010
(15.01.2010)
Dates of meetings for the Danish Pharmacopoeia Commission
(08.01.2010)
Minutes of the Pharmacovigilance Working Party's meeting held on 21-23 September.
(08.01.2010)
Side effects from Eltroxin® - status January 2010
(07.01.2010)
Minutes of Reimbursement Committee meeting no. 327
(07.01.2010)
The Danish Medicines Agency initiates the reassessment of reimbursement status of medicines in ATC group N
(07.01.2010)
135th session of the European Pharmacopoeia Commission
(07.01.2010)
Fees for clinical trials
(05.01.2010)
Side effects from Pandemrix® from 12 to 18 December 2009
(04.01.2010)
|
